Literature DB >> 33362777

Case Report: Overlapping Multiple Sclerosis With Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report and Review of Literature.

Ying Huang1, Qian Wang1, Silin Zeng1, Yaqing Zhang1, Liangyu Zou1, Xuejun Fu1, Qianhui Xu1.   

Abstract

Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder mediated by NMDAR antibodies, typically manifesting as behavioral complaints, psychosis, seizures, movement disorders, hypoventilation, and autonomic dysfunction. In recent years, the predisposing factors and pathophysiological mechanisms of anti-NMDAR encephalitis have been tried to be clarified. It has been recognized that an overlap may be observed between anti-NMDAR encephalitis and inflammatory demyelinating disease. However, anti-NMDAR encephalitis is rarely associated with multiple sclerosis. Here, we describe a Chinese female patient diagnosed with relapsing remitting multiple sclerosis who developed anti-NMDAR encephalitis. Further, we discuss the previously reported literature.
Copyright © 2020 Huang, Wang, Zeng, Zhang, Zou, Fu and Xu.

Entities:  

Keywords:  anti-NMDA antibody; anti-NMDA receptor encephalitis; atypical symptoms; multiple sclerosis; overlap

Mesh:

Substances:

Year:  2020        PMID: 33362777      PMCID: PMC7756053          DOI: 10.3389/fimmu.2020.595417

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  19 in total

1.  Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.

Authors:  Eugenia Martinez-Hernandez; Mar Guasp; Anna García-Serra; Estibaliz Maudes; Helena Ariño; Maria Sepulveda; Thaís Armangué; Ana P Ramos; Tamir Ben-Hur; Takahiro Iizuka; Albert Saiz; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2020-03-11       Impact factor: 9.910

2.  Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis.

Authors:  A Baheerathan; W J Brownlee; D T Chard; K Shields; R Gregory; S A Trip
Journal:  Mult Scler Relat Disord       Date:  2016-12-29       Impact factor: 4.339

Review 3.  N-Methyl-d-aspartate Receptor Antibody Encephalitis: A Concise Review of the Disorder, Diagnosis, and Management.

Authors:  Elizabeth M Staley; Rabia Jamy; Allan Q Phan; David A Figge; Huy P Pham
Journal:  ACS Chem Neurosci       Date:  2018-08-31       Impact factor: 4.418

4.  Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis.

Authors:  Robert Fleischmann; Harald Prüss; Berit Rosche; Markus Bahnemann; Harald Gelderblom; Katrin Deuschle; Lutz Harms; Ute Kopp; Klemens Ruprecht
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

5.  NMDAR (N-methyl-D-aspartate receptor) encephalitis in a patient with MS (multiple sclerosis): a rare and challenging case.

Authors:  Sadia Suleman; Qaiser Javed
Journal:  BMJ Case Rep       Date:  2018-02-17

6.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

7.  Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report.

Authors:  Anne Waschbisch; Bernd Kallmünzer; Stefan Schwab; Philipp Gölitz; Angela Vincent; De-Hyung Lee; Ralf A Linker
Journal:  BMC Res Notes       Date:  2014-12-23

8.  Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.

Authors:  O Stüve; P D Cravens; E M Frohman; J T Phillips; G M Remington; G von Geldern; S Cepok; M P Singh; J W Cohen Tervaert; M De Baets; D MacManus; D H Miller; E W Radü; E M Cameron; N L Monson; S Zhang; R Kim; B Hemmer; M K Racke
Journal:  Neurology       Date:  2008-11-05       Impact factor: 9.910

9.  Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.

Authors:  Maarten J Titulaer; Romana Höftberger; Takahiro Iizuka; Frank Leypoldt; Lindsey McCracken; Tania Cellucci; Leslie A Benson; Huidy Shu; Takashi Irioka; Makito Hirano; Gagandeep Singh; Alvaro Cobo Calvo; Kenichi Kaida; Pamela S Morales; Paul W Wirtz; Tomotaka Yamamoto; Markus Reindl; Myrna R Rosenfeld; Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Ann Neurol       Date:  2014-03       Impact factor: 10.422

10.  NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.

Authors:  Melanie Ramberger; Gabriel Bsteh; Kathrin Schanda; Romana Höftberger; Kevin Rostásy; Matthias Baumann; Fahmy Aboulenein-Djamshidian; Andreas Lutterotti; Florian Deisenhammer; Thomas Berger; Markus Reindl
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-08-13
View more
  4 in total

Review 1.  Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review.

Authors:  Shujiang Zhang; Yuan Yang; Wenyu Liu; Zuoxiao Li; Jinmei Li; Dong Zhou
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

2.  Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.

Authors:  Ran Zhou; Fei Jiang; Haobing Cai; Qiuming Zeng; Huan Yang
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

3.  Characteristics of Anti-Contactin1 Antibody-Associated Autoimmune Nodopathies With Concomitant Membranous Nephropathy.

Authors:  Qianhui Xu; Shuhu Liu; Peng Zhang; Zhen Wang; Xin Chang; Yulu Liu; Jiahe Yan; Ruirong He; Xiaoguang Luo; Liang-Yu Zou; Xiaofan Chu; Yi Guo; Suli Huang; Xuejun Fu; Ying Huang
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

4.  Concurrent Tuberculous Meningoencephalitis and Anti-NMDAR Encephalitis: A Case Report.

Authors:  Chen Xiaoli; Wang Qun; Li Jing; Yang Huan; Chen Si
Journal:  Front Neurol       Date:  2022-07-07       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.